From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

B Positive: Hepatitis B Guide for Primary Care

First published:

March 2025

Last published:

January 2025

Overview

The fourth edition of “B Positive: All you wanted to know about hepatitis B – a guide for primary care providers” has been updated to align with the most recent Australian consensus recommendations for the management of hepatitis B (2022). With an increased global focus on eliminating hepatitis B as a public health concern by 2030, it is crucial for primary care providers to be well-informed and actively engaged in the diagnosis, assessment, management, and treatment of hepatitis B.

This edition addresses the importance of testing, vaccination, chronic disease management, and appropriate referrals to specialist services. Explore this valuable resource to contribute to the health and well-being of individuals living with chronic hepatitis B.